Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty Industries: Is the Recent Pullback a Buying Opportunity?

Dieter Jaworski by Dieter Jaworski
November 27, 2025
in Commodities, Earnings, Penny Stocks
0
Almonty Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

Almonty Industries finds itself at the center of market attention following its third-quarter 2025 financial release and a significant strategic expansion into the United States. The stock closed yesterday’s session at CAD $8.48, recovering from an intraday low of CAD $7.98. This price action highlights the current volatility surrounding the company’s shares.

Strategic US Acquisition: Securing the Gentung Browns Lake Project

A major corporate development emerged in mid-November when Almonty announced the acquisition of the Gentung Browns Lake Tungsten project in Montana. This transaction grants the company full ownership of one of America’s most advanced, undeveloped tungsten assets.

Strategic implications of the deal include:
* Supply Chain Security: The move aligns with US government initiatives to bolster domestic sources of critical minerals.
* Portfolio Diversification: This expands Almonty’s operational footprint beyond its flagship Sangdong mine in South Korea and its interests in Portugal.
* Future Growth: The company is targeting production commencement for the second half of 2026.

Q3 2025 Financials: Robust Operational Performance

On November 3rd, Almonty disclosed its interim results for the third quarter, revealing a company in a clear state of transition. The figures underscore solid operational progress.

Key Q3 2025 Financial Highlights:
* Revenue: CAD $8.7 million (a 28% year-over-year increase)
* Net Income: CAD $33.2 million (significantly bolstered by accounting gains from the revaluation of warrant liabilities)
* Earnings Per Share: CAD $0.15 (basic) and CAD $0.13 (diluted)

Should investors sell immediately? Or is it worth buying Almonty?

The substantial 28% revenue growth points to the underlying strength of its tungsten operations. Furthermore, the shift to a positive earnings per share marks a notable turnaround from previous periods of reported losses.

Market Consolidation and Technical Perspective

The market’s reaction to these developments has been mixed, potentially indicating a classic “sell the news” scenario or a period of consolidation following earlier gains. The equity is currently trading below its 50-day moving average of CAD $9.44, suggesting a short-term corrective phase.

A Snapshot of Recent Trading:
* Closing Price: CAD $8.48
* Daily Low: CAD $7.98
* 50-Day Moving Average: CAD $9.44
* Trading Volume: Approximately 5.48 million shares

The gap between the current share price and the 50-day average may signal an oversold condition. Elevated trading volume indicates a transfer of ownership and could potentially be establishing a support level near the CAD $8.00 mark.

Sustained Analyst Confidence

Despite recent price weakness, analytical optimism remains. DA Davidson has reaffirmed its positive outlook, maintaining a “Buy” recommendation alongside a price target of USD $12.00. This target suggests substantial upside potential from current trading levels.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from January 11 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 11.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Vulcan Energy Stock
Analysis

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026
Procter & Gamble Stock
Analysis

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock
Analysis

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026
Next Post
UBS Stock

UBS Faces Headwinds as Hedge Fund Unit Grapples with Major Auto Supplier Collapse

Hecla Mining Stock

Hecla Mining: Nevada Discovery Fuels Investor Excitement

IonQ Stock

Leadership Shakeup at Quantum Computing Firm IonQ

Recommended

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

2 years ago
CryoLife Stock

Medical Device Specialist Artivion Maintains Strong Analyst Backing

3 months ago
Walgreens Boots Alliance Stock

Walgreens Concludes Public Trading Era Following Landmark Acquisition

3 months ago
MA stock news

Analysis of Short Interest and Financial Performance of US Bancorp

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Trending

Eli Lilly Stock
AI & Quantum Computing

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

by Felix Baarz
January 11, 2026
0

Eli Lilly and Company has opened 2026 with a clear strategic push to diversify and strengthen its...

Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026
Viking Therapeutics Stock

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

January 11, 2026
Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances
  • Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs
  • Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com